SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Surveillance of Transfusion-Transmissible Infections
16 references·5 citing·20 second hop
Surveillance of Transfusion-Transmissible Infections (2011)Surveillance of Transfusion-Transmissible…Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevalence, incidence, and re…Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Infectivity of human immunode…Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services (2007)Current incidence and estimat…Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT) (2005)Trends in risk of transfusion…Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (2005)Residual risk of transfusion …Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003 (2005)Estimates of the frequency of…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating…Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Detection of HIV-1 and HCV In…Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. (2003)Incidence and estimated rates…Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001 (2003)Estimation of the risk of hep…Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Current prevalence and incide…The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)The incidence/window period m…Estimates of Infectious Disease Risk Factors in US Blood Donors (1997)Estimates of Infectious Disea…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…The Retrovirus Epidemiology Donor Study (REDS): rationale and methods (1995)The Retrovirus Epidemiology D…Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Estimated Risk of Transmissio…Prevalence trends of transfusion-transmitted infections at a tertiary private hospital blood bank in Uganda: a retrospective 6-year review (2017–2022) (2025)Prevalence trends of transfus…Transfusion of HIV‐infected blood products despite highly sensitive nucleic acid testing (2019)Transfusion of HIV‐infected b…Risk‐based decision making in transfusion medicine (2018)Risk‐based decision making in…Molecular virology in transfusion medicine laboratory. (2013)Molecular virology in transfu…Cost‐effectiveness of questionnaires in preventing transfusion‐transmitted infections (2013)Cost‐effectiveness of questio…Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Collection and transfusion of blood and blood components in the United States, 1994 (1998)Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)The social organization of sexuality (1995)Attitudes toward blood donation incentives in the United States: implications for donor recruitment (2003)Effect of a National Disaster on Blood Supply and Safety (2003)First year donation patterns predict long‐term commitment for first‐time donors (2005)Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Evaluation of Screened Blood Donations for Human Immunodeficiency Virus Type 1 Infection by Culture and DNA Amplification of Pooled Cells (1991)International application of the Incidence Rate/Window Period model (2002)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Seroprevalence and incidence of transfusion‐transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa (2011)Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services (2012)Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation (2018)Prevention of transfusion-transmitted infections (2019)Transfusion-transmitted infections (2007)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited
  • 2004Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing535 cited
  • 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
  • 1995Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States346 cited
  • 2010Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing287 cited
  • 2009Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion221 cited
  • 1997Estimates of Infectious Disease Risk Factors in US Blood Donors180 cited
  • 1997The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection168 cited
  • 2007Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services154 cited
  • 2003Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.126 cited
  • 2003Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

126 cited
  • 2005Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus107 cited
  • 2005Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 200397 cited
  • 2005Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT)96 cited
  • 1995The Retrovirus Epidemiology Donor Study (REDS): rationale and methods89 cited
  • Cited by

    • 2018Risk‐based decision making in transfusion medicine22 cited
    • 2019Transfusion of HIV‐infected blood products despite highly sensitive nucleic acid testing22 cited
    • 2013Cost‐effectiveness of questionnaires in preventing transfusion‐transmitted infections20 cited
    • 2013Molecular virology in transfusion medicine laboratory.15 cited
    • 2025Prevalence trends of transfusion-transmitted infections at a tertiary private hospital blood bank in Uganda: a retrospective 6-year review (2017–2022)8 cited